NCT03086109 is a clinical trial of Risk factors in Cross-sectional Study, sponsored by Beijing Jishuitan Hospital.

Who is sponsoring NCT03086109?

NCT03086109 is sponsored by Beijing Jishuitan Hospital.

What drugs are being tested in NCT03086109?

Interventions in NCT03086109: Risk factors.

What condition does NCT03086109 study?

NCT03086109 studies Cross-sectional Study, Degenerative Disease Joint, Degenerative Disc Disease.

Is NCT03086109 still recruiting?

NCT03086109 is currently status unknown. Last updated 22 March 2017.

Last reviewed 2017-03-22 · How we verify

NCT03086109

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Prevalence of Bone Degenerative Diseases in Beijing - a Cross-sectional Study

Status unknown Last updated 22 March 2017

What this trial tests

trial testing Risk factors in Cross-sectional Study in 850 participants. Status unknown.

Timeline

1 October 2013

Primary endpoint
31 December 2017

31 December 2017

Quick facts

Lead sponsor	Beijing Jishuitan Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	850
Start date	1 October 2013
Primary completion	31 December 2017
Estimated completion	31 December 2017
Sites	1 location across China

Drugs / interventions tested

Risk factors

Conditions studied

Cross-sectional Study — all drugs for Cross-sectional Study →
Degenerative Disease Joint — all drugs for Degenerative Disease Joint →
Degenerative Disc Disease — all drugs for Degenerative Disc Disease →

Sponsor

Beijing Jishuitan Hospital

Who can join

Adults 18 to 65, any sex, with Cross-sectional Study or Degenerative Disease Joint. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this observational study is to investigate the prevalence and risk factors of bone degenerative diseases

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Risk factors

Trials testing the same drug.

NCT05492786 — High-risk Influenza Vaccine Alert · NA · completed
NCT04380662 — Risk Factors Worsening COVID19 for Out-patient With Home Monitoring · unknown
NCT04195048 — Mechanism and Outcome of Acute Ischemic Stroke in Cancer Patients · completed

Other Beijing Jishuitan Hospital trials

Trials by the same sponsor.

NCT07311616 — A Study on the Effectiveness of Preventive Extensive Release of the Rotator Interval and Joint Capsule to Reduce Postope · NA · not yet recruiting
NCT06756984 — Long-Term Outcomes of Different Surgical Techniques for Sacral Tarlov Cysts: A Prospective Cohort Study · not yet recruiting
NCT06872034 — The Efficacy and Safety of Venostan in Promoting Postoperative Swelling Reduction in Patients With Ankle Fractures · NA · recruiting
NCT06416631 — Artificial Intelligence Versus Maunal Planning in Robot Assisted Spinal Surgery · NA · not yet recruiting
NCT06480214 — Research on Key Technology Development and Clinical Application of Small Interactive Spinal Endoscopic Surgery Robot · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03086109 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Beijing Jishuitan Hospital
Last refreshed: 22 March 2017

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03086109.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing